Accessibility Statement Skip Navigation
  • Why PRWeb
  • How It Works
  • Who Uses It
  • Pricing
  • Login
  • GDPR
  • Create a Free Account
Return to PRWeb homepage
  • News
  • Resources
  • Contact
When typing in this field, a list of search results will appear and be automatically updated as you type.

Searching for your content...

No results found. Please change your search terms and try again.
  • News in Focus
      • Browse News Releases

      • All News Releases
      • Multimedia Gallery

      • All Multimedia
      • All Photos
      • All Videos
  • Business & Money
      • Auto & Transportation

      • Aerospace, Defense
      • Air Freight
      • Airlines & Aviation
      • Automotive
      • Maritime & Shipbuilding
      • Railroads and Intermodal Transportation
      • Supply Chain/Logistics
      • Transportation, Trucking & Railroad
      • Travel
      • Trucking and Road Transportation
      • View All Auto & Transportation

      • Business Technology

      • Blockchain
      • Broadcast Tech
      • Computer & Electronics
      • Computer Hardware
      • Computer Software
      • Data Analytics
      • Electronic Commerce
      • Electronic Components
      • Electronic Design Automation
      • Financial Technology
      • High Tech Security
      • Internet Technology
      • Nanotechnology
      • Networks
      • Peripherals
      • Semiconductors
      • View All Business Technology

      • Entertain­ment & Media

      • Advertising
      • Art
      • Books
      • Entertainment
      • Film and Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • View All Entertain­ment & Media

      • Financial Services & Investing

      • Accounting News & Issues
      • Acquisitions, Mergers and Takeovers
      • Banking & Financial Services
      • Bankruptcy
      • Bond & Stock Ratings
      • Conference Call Announcements
      • Contracts
      • Cryptocurrency
      • Dividends
      • Earnings
      • Earnings Forecasts & Projections
      • Financing Agreements
      • Insurance
      • Investments Opinions
      • Joint Ventures
      • Mutual Funds
      • Private Placement
      • Real Estate
      • Restructuring & Recapitalization
      • Sales Reports
      • Shareholder Activism
      • Shareholder Meetings
      • Stock Offering
      • Stock Split
      • Venture Capital
      • View All Financial Services & Investing

      • General Business

      • Awards
      • Commercial Real Estate
      • Corporate Expansion
      • Earnings
      • Environmental, Social and Governance (ESG)
      • Human Resource & Workforce Management
      • Licensing
      • New Products & Services
      • Obituaries
      • Outsourcing Businesses
      • Overseas Real Estate (non-US)
      • Personnel Announcements
      • Real Estate Transactions
      • Residential Real Estate
      • Small Business Services
      • Socially Responsible Investing
      • Surveys, Polls and Research
      • Trade Show News
      • View All General Business

  • Science & Tech
      • Consumer Technology

      • Artificial Intelligence
      • Blockchain
      • Cloud Computing/Internet of Things
      • Computer Electronics
      • Computer Hardware
      • Computer Software
      • Consumer Electronics
      • Cryptocurrency
      • Data Analytics
      • Electronic Commerce
      • Electronic Gaming
      • Financial Technology
      • Mobile Entertainment
      • Multimedia & Internet
      • Peripherals
      • Social Media
      • STEM (Science, Tech, Engineering, Math)
      • Supply Chain/Logistics
      • Wireless Communications
      • View All Consumer Technology

      • Energy & Natural Resources

      • Alternative Energies
      • Chemical
      • Electrical Utilities
      • Gas
      • General Manufacturing
      • Mining
      • Mining & Metals
      • Oil & Energy
      • Oil and Gas Discoveries
      • Utilities
      • Water Utilities
      • View All Energy & Natural Resources

      • Environ­ment

      • Conservation & Recycling
      • Environmental Issues
      • Environmental Policy
      • Environmental Products & Services
      • Green Technology
      • Natural Disasters
      • View All Environ­ment

      • Heavy Industry & Manufacturing

      • Aerospace & Defense
      • Agriculture
      • Chemical
      • Construction & Building
      • General Manufacturing
      • HVAC (Heating, Ventilation and Air-Conditioning)
      • Machinery
      • Machine Tools, Metalworking and Metallurgy
      • Mining
      • Mining & Metals
      • Paper, Forest Products & Containers
      • Precious Metals
      • Textiles
      • Tobacco
      • View All Heavy Industry & Manufacturing

      • Telecomm­unications

      • Carriers and Services
      • Mobile Entertainment
      • Networks
      • Peripherals
      • Telecommunications Equipment
      • Telecommunications Industry
      • VoIP (Voice over Internet Protocol)
      • Wireless Communications
      • View All Telecomm­unications

  • Lifestyle & Health
      • Consumer Products & Retail

      • Animals & Pets
      • Beers, Wines and Spirits
      • Beverages
      • Bridal Services
      • Cannabis
      • Cosmetics and Personal Care
      • Fashion
      • Food & Beverages
      • Furniture and Furnishings
      • Home Improvement
      • Household, Consumer & Cosmetics
      • Household Products
      • Jewelry
      • Non-Alcoholic Beverages
      • Office Products
      • Organic Food
      • Product Recalls
      • Restaurants
      • Retail
      • Supermarkets
      • Toys
      • View All Consumer Products & Retail

      • Entertain­ment & Media

      • Advertising
      • Art
      • Books
      • Entertainment
      • Film and Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • View All Entertain­ment & Media

      • Health

      • Biometrics
      • Biotechnology
      • Clinical Trials & Medical Discoveries
      • Dentistry
      • FDA Approval
      • Fitness/Wellness
      • Health Care & Hospitals
      • Health Insurance
      • Infection Control
      • International Medical Approval
      • Medical Equipment
      • Medical Pharmaceuticals
      • Mental Health
      • Pharmaceuticals
      • Supplementary Medicine
      • View All Health

      • Sports

      • General Sports
      • Outdoors, Camping & Hiking
      • Sporting Events
      • Sports Equipment & Accessories
      • View All Sports

      • Travel

      • Amusement Parks and Tourist Attractions
      • Gambling & Casinos
      • Hotels and Resorts
      • Leisure & Tourism
      • Outdoors, Camping & Hiking
      • Passenger Aviation
      • Travel Industry
      • View All Travel

  • Policy & Public Interest
      • Policy & Public Interest

      • Advocacy Group Opinion
      • Animal Welfare
      • Congressional & Presidential Campaigns
      • Corporate Social Responsibility
      • Domestic Policy
      • Economic News, Trends, Analysis
      • Education
      • Environmental
      • European Government
      • FDA Approval
      • Federal and State Legislation
      • Federal Executive Branch & Agency
      • Foreign Policy & International Affairs
      • Homeland Security
      • Labor & Union
      • Legal Issues
      • Natural Disasters
      • Not For Profit
      • Patent Law
      • Public Safety
      • Trade Policy
      • U.S. State Policy
      • View All Policy & Public Interest

  • People & Culture
      • People & Culture

      • Aboriginal, First Nations & Native American
      • African American
      • Asian American
      • Children
      • Diversity, Equity & Inclusion
      • Hispanic
      • Lesbian, Gay & Bisexual
      • Men's Interest
      • People with Disabilities
      • Religion
      • Senior Citizens
      • Veterans
      • Women
      • View All People & Culture

  • Hamburger menu
  • Cision PRWeb provides efficient communication tools to continuously engage with target audiences across multiple online channels
  • Create a Free Account
    • ALL CONTACT INFO
    • Contact Us


      11AM ET Sunday – 8PM ET Friday

  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR
  • News in Focus
    • Browse All News
    • Multimedia Gallery
  • Business & Money
    • Auto & Transportation
    • Business Technology
    • Entertain­ment & Media
    • Financial Services & Investing
    • General Business
  • Science & Tech
    • Consumer Technology
    • Energy & Natural Resources
    • Environ­ment
    • Heavy Industry & Manufacturing
    • Telecomm­unications
  • Lifestyle & Health
    • Consumer Products & Retail
    • Entertain­ment & Media
    • Health
    • Sports
    • Travel
  • Policy & Public Interest
  • People & Culture
    • People & Culture
  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR
  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR
  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR

Experience with BioTrace Medical's Tempo Temporary Pacing Lead in Management of Bradyarrhythmia Presented at the American Heart Association's Scientific Sessions 2021

Single-center retrospective analysis further demonstrates the Tempo Lead is safe and effective for temporary pacing and ambulation in cardiac electrophysiology applications


News provided by

BioTrace Medical Inc

Nov 15, 2021, 07:00 ET

Share this article

Share toX

Share this article

Share toX

The Tempo® Temporary Pacing Lead (BioTrace Medical Inc, Menlo Park CA)
The Tempo® Temporary Pacing Lead (BioTrace Medical Inc, Menlo Park CA)

MENLO PARK, Calif., Nov. 15, 2021 /PRNewswire-PRWeb/ -- BioTrace Medical, Inc., the leader in innovative temporary cardiac pacing technology, today announced the company's Tempo® Temporary Pacing Lead was featured in a clinical study presented at the American Heart Association's Scientific Sessions 2021, held November 13-15 in Orlando, Florida.

The study, titled "A Retrospective Analysis of a Single-Center Experience with the Tempo Temporary Pacing Lead in Management of Bradyarrhythmia and Other Cardiac Electrophysiology Procedures", analyzed a series of twelve consecutive patients who underwent Tempo Lead placement for temporary pacing at OhioHealth Riverside Methodist Hospital in Columbus, Ohio.

“The Tempo Lead is very useful for the support of temporary bradyarrhythmias that require reliable early- or medium-term temporary pacing as a bridge to resolution or permanent pacemaker implantation,” said Anish K. Amin, MD, cardiac electrophysiologist at OhioHealth Riverside Methodist Hospital.

Post this

Twelve consecutive patients (83% male, mean age 71.3 ± 10.1 years) who underwent Tempo Lead placement for temporary pacing were retrospectively reviewed (75% symptomatic bradyarrhythmia, 25% other indications including permanent lead malfunction, permanent pacemaker infection, and complete heart block.) The Tempo Lead was successfully positioned and fixed in the right ventricle in all twelve cases with no perforations, pericardial effusions, or device-related arrhythmias. Access was femoral in eight patients (67%) and jugular in three patients (25%), with one access point not indicated.

Procedural mean pace capture threshold (PCT) was 0.96 ± 0.74 mA (n=10). Mean lead indwelling duration was 53.5 hours with a range of 20.9 hours to 5.9 days (n= 11). Three patients were ambulatory (at least bed-to-chair) with the Tempo Lead in place without complications and with maintenance of thresholds <1mA.

The Tempo Lead's novel design – featuring retractable stabilizer loops and a soft tip – minimizes the risks of dislodgment and perforation, ensures stability during rapid pacing, and facilitates patient ambulation in recovery.

"The Tempo Lead is very useful for the support of temporary bradyarrhythmias that require reliable early- or medium-term temporary pacing as a bridge to resolution or permanent pacemaker implantation," said Anish K. Amin, MD, cardiac electrophysiologist at OhioHealth Riverside Methodist Hospital. "Its unique design provides temporary pacing without the risk of dislodgment, loss of pace capture, or perforation inherent in conventional temporary leads."

With U.S. FDA clearance and CE certification, the Tempo Lead is the only active fixation temporary pacing lead available in the world. The Tempo Lead has been used in more than 12,000 U.S. procedures with an excellent safety and performance profile, as demonstrated by reported "real-world" 0.04% cardiac perforation rate and a 0.11% intermittent/loss of pace capture rate.1 (Conventional temporary pacing leads exhibit cardiac perforation rates ranging from 0.6% to 4.0%, and dislodgment/loss of pace capture rates between 10% and 37%.2)

About BioTrace Medical

BioTrace Medical, Inc., a private venture-backed company based in Menlo Park, California, is dedicated to reinventing temporary pacing to improve patient outcomes and reduce hospital costs. For more information, visit http://www.biotracemedical.com.

(1) Company data on file as of October 2021.
(2) Metkus, et al. Chest. 2019; Lopez, et al. Rev Esp Cardiol. 2004; Betts, Postgrad Med J. 2003; Jowett, et al. Postgrad Med J. 1989; Austin, et al. Am J Cardiol. 1982; Gammage, Heart 2000; Lumia et al. Chest 1973

APM042-01.A

Media Contact

Kevin Tausend, BioTrace Medical Inc, +1 6507795124, [email protected]

Twitter

SOURCE BioTrace Medical Inc

Related Links

http://www.biotracemedical.com

Modal title

Poster image P1039 - A Retrospective Analysis of a Single-Center Experience With the Tempo Temporary Pacing Lead in Management of Bradyarrhythmia and Other EP Procedures
Poster image P1039 - A Retrospective Analysis of a Single-Center Experience With the Tempo Temporary Pacing Lead in Management of Bradyarrhythmia and Other EP Procedures
Poster image P1039 - A Retrospective Analysis of a Single-Center Experience With the Tempo Temporary Pacing Lead in Management of Bradyarrhythmia and Other EP Procedures

Contact PRWeb

  • 11AM ET Sunday – 8PM ET Friday
  • Contact Us

About PRWeb

  • About PRWeb
  • Partners
  • Partnership Programs
  • Editorial Guidelines
  • Resources

Why PRWeb

  • Why PRWeb
  • How It Works
  • Who Uses It
  • Pricing

Accounts

  • Create a Free Account
  • Log in
  • Contact Us

Do not sell or share my personal information:

  • Submit via [email protected] 
  • Call Privacy toll-free: 877-297-8921

Contact Cision

Products

About

My Services
  • All News Releases
  • Online Member Center
  • ProfNet
Cision Distribution Helpline
888-776-0942
  • Legal
  • Site Map
  • RSS
  • Cookie Settings
Copyright © 2025 Cision US Inc.